Chris Scullin
Partner·Norwest
Bio
Professional summary
Chris Scullin is a Partner at Norwest focused on growth equity investments in software, tech services, healthcare technology, and data businesses. Before Norwest, he spent more than 10 years at Bain Capital, where he worked on application-software buyouts, launched Bain Capital's West Coast PE office, and helped drive the Athenahealth buyout. Earlier, he was an associate consultant at Bain & Company in Los Angeles.
Notable companies
Selected portfolio companies the partner has backed
Background
Career, education, and skills
Career history
- Norwest Venture PartnersPartner2024 – Present
- Bain CapitalPrincipal
- Bain & CompanyAssociate Consultant
Education
- Harvard Business SchoolMBA
- Boston CollegeBA
Other partners at Norwest
12 more profiles
Abishek Balakrishnan
Investor
Norwest
Norwest growth equity investor focused on healthcare services, IT, devices, and digital health.
Aidan Greenstein
Investor
Norwest
Norwest growth equity investor covering technology, business services, media, and consumer.
Amalia Mackenzie
Investor
Norwest
Norwest venture investor focused on consumer and enterprise software.
Amy Brand
Investor
Norwest
Norwest growth equity investor and former Barclays financial sponsors banker.
Andrew Ellis
Investor
Norwest
Norwest growth equity investor focused on software and tech-enabled services.
Angela Johnson
Vice President
Norwest
Norwest growth equity VP focused on technology, business services, media, and consumer.
Anjini K.
Investor
Norwest
Norwest healthtech venture investor with prior Oscar Health and McKinsey experience.
Ankit Prasad
Norwest India
Norwest
Norwest India investor focused on venture and growth equity across Indian companies.
Apurva Oak
Investor
Norwest
Healthcare growth investor focused on software and services at Norwest.
Aria Shah
Investment Professional
Norwest
Growth investment professional with healthcare and venture capital experience.
Assaf Harel
Partner
Norwest
Norwest Partner focused on Israeli-related multi-stage technology investments.
Brian Matesic, MD
Principal
Norwest
Life sciences investor backing early- to mid-stage biotech and medtech companies.